abstract |
A method of inhibiting colorectal cancer, comprising administering an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof to a mammal in need thereof.n n n <Formula I>n n n n n n n n Wheren n n R 1 and R 3 are independently hydrogen, —CH 3 , (a) Or (b) Wherein Ar is optionally substituted phenyl;n n n R 2 is selected from the group consisting of pyrrolidino, hexamethyleneimino or piperidino. |